Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism in IHD, Diagnostic and Prognostic Correlation

Mourad Saad Shaker;

Abstract


Background: Thrombin-activatable fibrinolysis inhibitor (TAFI) is a recently identified fibrinolysis inhibitor. TAFI is activated by the thrombin-thrombomodulin complex and activated TAFI suppresses fibrinolysis by removal of carboxy-terminal lysine (and


Other data

Title Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism in IHD, Diagnostic and Prognostic Correlation
Authors Mourad Saad Shaker
Keywords Thrombin-Activatable Fibrinolysis Inhibitor Gene Polymorphism in IHD, Diagnostic and Prognostic Correlation
Issue Date 2008
Description 
Background: Thrombin-activatable fibrinolysis inhibitor (TAFI) is a recently identified fibrinolysis inhibitor. TAFI is activated by the thrombin-thrombomodulin complex and activated TAFI suppresses fibrinolysis by removal of carboxy-terminal lysine (and

Attached Files

File SizeFormat
20437Dr. Mourad Saad Shaker.pdf306.61 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 2 in Shams Scholar
downloads 6 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.